surfactant administration
PreclinicalSmall molecule
surfactant administration is one of 5 small molecule programs targeting Catheter. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Catheter
#DrugCompanyPhaseTrials
1REGN7508
RegeneronPhase 2
REGN9933
RegeneronPhase 2
Inhaled Nitric Oxide
LLee's Pharmaceutical Limited
Preclinical
surfactant administration
HHaEmek Medical Center, Israel
Preclinical
No Heparin
TThe University of Texas Health Science Center at San Antonio
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for surfactant administration. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- HHaEmek Medical Center, Israel